Cargando…

COVID-19 and sickle cell disease

Detalles Bibliográficos
Autores principales:	Menapace, Laurel A., Thein, Swee Lay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604559/ https://www.ncbi.nlm.nih.gov/pubmed/33131239 http://dx.doi.org/10.3324/haematol.2020.255398

Ejemplares similares

Therapeutic advances in sickle cell disease in the last decade
por: Shet, Arun S., et al.
Publicado: (2017)

Neutrophils remain detrimentally active in hydroxyurea-treated patients with sickle cell disease
por: Barbu, Emilia Alina, et al.
Publicado: (2019)

World Sickle Cell Day 2016 : A time for appraisal
por: Thein, Mya S., et al.
Publicado: (2016)

The carrier state for sickle cell disease is not completely harmless
por: Xu, Julia Zhe, et al.
Publicado: (2019)

Research in Sickle Cell Disease: From Bedside to Bench to Bedside
por: Salinas Cisneros, Gabriel, et al.
Publicado: (2021)

GlycA is not a useful biomarker of inflammation in sickle cell disease
por: Weisman, Julie K., et al.
Publicado: (2018)

Recent Advances in the Treatment of Sickle Cell Disease
por: Salinas Cisneros, Gabriel, et al.
Publicado: (2020)

Experimental Generation of SNP Haplotype Signatures in Patients with Sickle Cell Anaemia
por: Menzel, Stephan, et al.
Publicado: (2010)

Catheter‐related right atrial thrombus in sickle cell disease
por: Zhao, Chen, et al.
Publicado: (2017)

Increased prevalence of renal cysts in patients with sickle cell disease
por: Meeks, Daveena, et al.
Publicado: (2017)

Genetic variants at HbF‐modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania
por: Mtatiro, Siana Nkya, et al.
Publicado: (2014)

Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal
por: Thein, Swee Lay, et al.
Publicado: (2020)

Two Consecutive Episodes of Severe Delayed Hemolytic Transfusion Reaction in a Sickle Cell Disease Patient
por: Mpinganzima, Clarisse, et al.
Publicado: (2020)

Red Blood Cell Membrane Cholesterol May Be a Key Regulator of Sickle Cell Disease Microvascular Complications
por: Niesor, Eric J., et al.
Publicado: (2022)

Post-translational modification as a response to cellular stress induced by hemoglobin oxidation in sickle cell disease
por: Strader, Michael Brad, et al.
Publicado: (2020)

Genetic variants of PKLR are associated with acute pain in sickle cell disease
por: Wang, Xunde, et al.
Publicado: (2022)

Fetal Hemoglobin is Associated with Peripheral Oxygen Saturation in Sickle Cell Disease in Tanzania
por: Nkya, Siana, et al.
Publicado: (2017)

Associations between environmental factors and hospital admissions for sickle cell disease
por: Piel, Frédéric B., et al.
Publicado: (2017)

A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia
por: Adeyemo, Titilope A., et al.
Publicado: (2018)

Genome wide association study of silent cerebral infarction in sickle cell disease (HbSS and HbSC)
por: Brewin, John N., et al.
Publicado: (2020)

Detection and Quantification of Histone H4 Citrullination in Early NETosis With Image Flow Cytometry Version 4
por: Barbu, Emilia A., et al.
Publicado: (2020)

Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarction
por: Tewari, Sanjay, et al.
Publicado: (2018)

Allosteric control of hemoglobin S fiber formation by oxygen and its relation to the pathophysiology of sickle cell disease
por: Henry, Eric R., et al.
Publicado: (2020)

Genetic Variation on Chromosome 6 Influences F Cell Levels in Healthy Individuals of African Descent and HbF Levels in Sickle Cell Patients
por: Creary, Lisa E., et al.
Publicado: (2009)

Phenotypic screening of the ReFRAME drug repurposing library to discover new drugs for treating sickle cell disease
por: Metaferia, Belhu, et al.
Publicado: (2022)

Genome Wide Association Study of Fetal Hemoglobin in Sickle Cell Anemia in Tanzania
por: Mtatiro, Siana Nkya, et al.
Publicado: (2014)

Sickle Cell Disease and Fetal Hemoglobin
por: Rivera, Alicia
Publicado: (2018)

Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer
por: Mtatiro, Siana N, et al.
Publicado: (2015)

Pyridoxamine: another vitamin for sickle cell disease?
por: Telen, Marilyn J.
Publicado: (2020)

Sickle-cell disease: a call to action
por: Piel, Frédéric B., et al.
Publicado: (2015)

Pulmonary Haemodynamics in Sickle Cell Disease Are Driven Predominantly by a High-Output State Rather Than Elevated Pulmonary Vascular Resistance: A Prospective 3-Dimensional Echocardiography/Doppler Study
por: Mushemi-Blake, Sitali, et al.
Publicado: (2015)

Sickle cell disease: Status with particular reference to India
por: Rees, David C., et al.
Publicado: (2016)

COVID-19 outcomes in sickle cell disease and sickle cell trait
por: Christian, Jana, et al.
Publicado: (2022)

Sickle cell disease: Progress made & challenges ahead
por: Odame, Isaac, et al.
Publicado: (2020)

Is Sickle Cell Anemia a Neglected Tropical Disease?
por: Ware, Russell E.
Publicado: (2013)

Comorbidities in sickle cell disease: Adult providers needed!
por: Ogu, Ugochi O., et al.
Publicado: (2018)

Sickle cell disease in Saudi Arabia: A challenge or not
por: Alotaibi, Maha Mohammed
Publicado: (2017)

Sickle Cell Disease: Current Understanding and Future Options
por: Varelas, Christos, et al.
Publicado: (2023)

SICKLE CELL DISEASE AND COVID-19
por: HANNA, SANDRINE, et al.
Publicado: (2021)

Sickle Cell Anæmia in India
Publicado: (1952)

Cannot write session to /tmp/vufind_sessions/sess_ae46p3eq8jnmhq5826o5uv151r